enGene Therapeutics Inc. – Indentures

NASDAQ: ENGN
Share price (5/22/26): $1.64
Market cap (5/22/26): $110 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

from S-3 81 pages enGene Holdings Inc. as Issuer and [ ] as U.S. Trustee and [ ] as Canadian Trustee Indenture Dated as of [ ]

from 8-K 21 pages This Warrant Certificate, and the Right to Purchase Common Shares Evidenced Hereby, Will Be Void and of No Value Unless Exercised on or Before 5:00 P.M. (Vancouver Time) on [●]2. Warrant Certificate enGene Holdings Inc. a Corporation Existing Under the Laws of British Columbia (The “Corporation”) [●]3

from 8-K 11 pages Pre-Funded Warrant to Purchase Common Shares

from S-3 79 pages enGene Holdings Inc. as Issuer and [ ] as U.S. Trustee and [ ] as Canadian Trustee Indenture Dated as of [ ]

from 10-K 6 pages Description of enGene Securities

from 8-K 20 pages This Warrant Certificate, and the Right to Purchase Common Shares Evidenced Hereby, Will Be Void and of No Value Unless Exercised on or Before 5:00 P.M. (Vancouver Time) on [•]2. Warrant Certificate enGene Holdings Inc. a Corporation Existing Under the Laws of British Columbia (The “Corporation”) [•]3

from 8-K 15 pages Warrant Assignment, Assumption and Amendment Agreement

from S-4/A 1 page Incorporated Under the Canada Business Corporations Act

from S-4/A 1 page Incorporated Under the Canada Business Corporations Act